Darb-Esfahani, S <br/><br/>
Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer.  [electronic resource] 

 -  British journal of cancer  Nov 2012 
 - 1892-900 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-1827 
<br/><br/><label>Standard No.: </label>10.1038/bjc.2012.475  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Breast Neoplasms--chemistry<br/>Cell Line, Tumor<br/>Clinical Trials, Phase III as Topic<br/>Estrogen Receptor alpha--analysis<br/>Female<br/>Gene Expression Profiling<br/>Humans<br/>Logistic Models<br/>RNA, Messenger--analysis<br/>Receptor, ErbB-2--analysis<br/>Receptors, Progesterone--analysis<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Thymosin--genetics